These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 294468)

  • 1. The bioavailability of an iron polymaltose complex for treatment of iron deficiency.
    Jacobs P; Wormald L
    J Med; 1979; 10(4):279-85. PubMed ID: 294468
    [No Abstract]   [Full Text] [Related]  

  • 2. Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex. Clinical and experimental studies.
    Jacobs P
    Arzneimittelforschung; 1987 Jan; 37(1A):113-6. PubMed ID: 3566865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study.
    Jacobs P; Wormald LA; Gregory MC
    S Afr Med J; 1979 Jun; 55(26):1065-72. PubMed ID: 472964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose.
    Jacobs P; Johnson G; Wood L
    J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iron deficiency anemia caused by undernutrition in childhood. Treatment with polymaltose iron].
    Louzada JL; Louzada GZ
    Hospital (Rio J); 1970 Apr; 77(4):1369-74. PubMed ID: 5315580
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the metabolism of 2 injectable iron preparations (sorbitol iron and polymaltose iron) with the metabolism of transferrin and hemoglobin iron].
    Dresch C; Boulard M; Najean Y
    Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):47-65. PubMed ID: 951183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals.
    Johnson G; Jacobs P
    Exp Hematol; 1990 Nov; 18(10):1064-9. PubMed ID: 2209759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.
    Dietzfelbinger H
    Arzneimittelforschung; 1987 Jan; 37(1A):107-12. PubMed ID: 3566864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Grimstad T; Berstad A; Berge RK; Hausken T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):831-8. PubMed ID: 16225492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IV iron or oral iron in anaemic patient with CKD].
    Frimat L; Thilly N; Boini S
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S347-9. PubMed ID: 17373282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bioavailability of oral iron preparations].
    Müller A; Geisser P
    Dtsch Med Wochenschr; 1979 Aug; 104(31):1112-3. PubMed ID: 456286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bioavailability of oral iron preparations].
    Dietzfelbinger H; Kaboth W
    Dtsch Med Wochenschr; 1979 Nov; 104(45):1614-5. PubMed ID: 498993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioavailability of oral iron preparations].
    Metzger KH
    Dtsch Med Wochenschr; 1979 Aug; 104(35):1247. PubMed ID: 477528
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioavailability of various iron preparations following oral medication].
    Heilmann E; Keim G
    Fortschr Med; 1980 Dec; 98(47-48):1871-4. PubMed ID: 7216093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme iron polypeptide: a radically different oral iron.
    Nephrol News Issues; 2002 Mar; 16(4):39, 41. PubMed ID: 11902061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of iron deficiencies].
    Waller HD
    Verh Dtsch Ges Inn Med; 1978; (84):78-89. PubMed ID: 369210
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bio-availability of oral iron preparations (author's transl)].
    Dietzfelbinger H; Kaboth W
    Dtsch Med Wochenschr; 1979 May; 104(20):742-6. PubMed ID: 446286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.